A 77-year-old man was admitted for moderate acute respiratory distress syndrome (ARDS) requiring invasive mechanical ventilation, with PCR confirmed SARS-Cov-2 infection. Protective ventilation strategy included: tidal volume of 6 mL/kg (ideal body weight), Positive End Expiratory Pressure (PEEP) titration with plateau pressure inferior to 28 cmH~2~O, neuromuscular blockers, and prone position. At day 5 of ventilation, we observed acute chest and collar subcutaneous emphysema associated with bradycardia at 47 bpm. Chest CT scan revealed diffuse pneumomediastinum (white arrows) with diffuse subcutaneous emphysema (black arrows) ([Fig. 1](#fig0005){ref-type="fig"} ). There was no pneumothorax and no evidence for tracheal or esophageal perforation. No intervention was required. Pneumomediastinum are observed in critically ill coronavirus disease 2019 (COVID-19) patients. Whether or not this complication is related to the mechanical ventilation or to the COVID-19 pathogeny *per se* remains an unanswered question.Figure 1
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